ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
복합주사제 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 177억 달러에서 2025년에는 197억 7,000만 달러에 달하고, CAGR 11.7%로 확대될 전망입니다. 과거 조사기간 내 성장은 만성질환의 유병률 증가, 표적 생물학적 제제에 대한 수요 증가, 자가 투여 디바이스의 채용 확대, 암 영역에서의 용도 확대, 바이오시밀러에 대한 규제 당국의 승인 증가와 관련되어 있습니다.
복합주사제 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 11.3%로 303억 8,000만 달러로 성장할 전망입니다. 예측 기간 동안 예측되는 성장은 맞춤 의료에 대한 관심 증가, 건강 관리 지출 증가, 자가면역 질환에의 응용 확대, 저침습 치료에 대한 환자의 선호도 증가, 자가 투여 장치에 대한 수요 증가에 의해 발생합니다. 예측 기간 동안의 주요 동향은 생물학적 치료의 진보, 약물 전달 시스템의 혁신, 표적 전달을 위한 나노기술의 개발, 콜드체인 물류의 개선, 펩티드 및 단백질 주사 치료제의 진보 등을 포함합니다.
만성질환의 유병률 상승은 향후 수년간 복합주사제 시장의 성장을 가속화할 것으로 예측됩니다. 만성 질환은 일반적으로 진행이 느리고 지속적인 관리가 필요한 장기적인 병리입니다. 고령자는 당뇨병, 심장병, 관절염 등의 질환에 걸리기 쉽기 때문에 인구의 고령화 등의 요인이 이 증가에 기여하고 있습니다. 복잡한 주사제는 증상을 조절하고 질병의 진행을 늦추는 데 도움이 되는 표적 약물을 투여함으로써 이러한 만성 질환의 관리를 돕습니다. 예를 들어 영국의 공중보건기구인 OHID(Office for Health Improvement &Disparities)는 당뇨병을 앓는 성인 수가 2021년 5억 3,700만 명에서 2030년에는 6억 4,300만 명으로 증가할 것으로 예측했습니다. 이와 같이 만성질환의 부담 증가는 복합주사제 시장의 수요를 견인하고 있습니다.
약물 전달 시스템의 주요 기업은 환자의 편의성을 향상시키고, 치료의 필요성을 높이며, 정확하고 안전한 약물 투여를 보장하고, 복잡한 생물학적 제형의 효과적인 전달을 촉진하기 위해 자동 주사기 투여 형태와 같은 혁신에 주력하고 있습니다. 자동 주사기는 특정 약물 복용량을 안전하고 정확하게 전달하도록 설계된 프리필드 자가 투여 주사기로, 생물학적 제제 및 기타 복잡한 약물에 자주 사용됩니다. 예를 들어, 2024년 1월에는 일본 제네릭 의약품 회사인 다이쇼 제약 주식회사가 주사기 제조 판매를 시작했습니다. 예를 들어, 일본의 제네릭 의약품 제조업체인 다이쇼 제약 주식회사는 2024년 1월 나노졸라 피하주 30mg을 출시했습니다. 이 환자 친화적인 주사기는 자가 주사가 쉽고 실수로 바늘이 박히는 것을 방지하는 바늘 커버 기능을 갖추고 있습니다. 이를 통해 류마티스 관절염 환자는 4주에 한 번 간편하게 치료를 받을 수 있게 되고, 다이쇼 제약은 기존의 주사기 제형에 더하여 치료 옵션을 넓히게 됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 복합주사제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 복합주사제 시장 : 성장률 분석
세계의 복합주사제 시장 실적 : 규모와 성장(2019-2024년)
세계의 복합주사제 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 복합주사제 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 복합주사제 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
단일클론항체
유전자 치료제
백신 단백질 및 펩티드
항체 약물 복합체(ADC)
세계의 복합주사제 시장 : 치료 영역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
종양
당뇨병
자가면역질환
신경질환
심혈관질환
감염증
세계의 복합주사제 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
정맥
피하(SC)
근육(IM)
경막외
피내
세계의 복합주사제 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
직접 판매
약국
전자상거래
판매자
도매업체
세계의 복합주사제 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
외래수술센터(ASC)
전문 클리닉
가정 헬스케어
연구기관
세계의 복합주사제 시장 세분화 : 단일클론항체 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
키메라 단일클론항체
인간화 단일클론항체
완전 인간형 단일클론항체
이중특이성 단일클론항체
세계의 복합주사제 시장 세분화 : 유전자 치료제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
체세포 유전자 치료
생식세포 계열 유전자 치료
생체외 유전자 치료
생체내 유전자 치료
세계의 복합주사제 시장 세분화 : 백신 단백질 및 펩티드 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
재조합 단백질
합성 펩티드
mRNA 백신
바이러스 벡터 백신
단백질 아단위 백신
세계의 복합주사제 시장 세분화 : 항체 약물 복합체 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
절단성 링커 항체 약물 복합체
비분열성 링커 항체 약물 복합체
세포독성 페이로드 항체 약물 복합체
표적 특이성 항체 약물 복합체
제7장 지역별/국가별 분석
세계의 복합주사제 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 복합주사제 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
복합주사제 시장 : 경쟁 구도
복합주사제 시장 : 기업 프로파일
Johnson & Johnson Pharmaceutical : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bristol-Myers Squibb Company
Novo Nordisk
Takeda Pharmaceutical Company Limited
Amgen Inc.
Boehringer Ingelheim GmbH
Baxter Healthcare Corporation
Fresenius Kabi
Sun Pharmaceutical Industries Ltd.
Hikma Pharmaceuticals
Indivior PLC
Amphastar Pharmaceuticals Inc.
Braun Melsungen AG
Ferring Pharmaceuticals
Oakwood Labs
ForDoz Pharma
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
복합주사제 시장(2029년) : 새로운 기회를 제공하는 국가
복합주사제 시장(2029년) : 새로운 기회를 제공하는 부문
복합주사제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Complex injectables refer to advanced pharmaceutical products that require sophisticated formulation and sterile manufacturing processes for injection. They are used to deliver targeted therapies, vaccines, or biologics directly into the body, addressing diseases that cannot be effectively treated with conventional oral medications.
The primary product types of complex injectables include monoclonal antibodies, gene therapies, vaccines, proteins and peptides, and antibody-drug conjugates (ADCs). Monoclonal antibodies are laboratory-produced molecules that mimic the immune system's ability to recognize and bind specific antigens. They are applied across therapeutic areas such as oncology, diabetes, autoimmune disorders, neurological disorders, cardiovascular diseases, and infectious diseases. Routes of administration include intravenous (IV), subcutaneous (SC), intramuscular (IM), epidural, and intradermal. Distribution occurs through direct sales, pharmacies, e-commerce platforms, distributors, and wholesalers. Key end users include hospitals, ambulatory surgical centers, specialty clinics, home healthcare providers, and research institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The complex injectable market research report is one of a series of new reports from The Business Research Company that provides complex injectable market statistics, including the complex injectable industry global market size, regional shares, competitors with the complex injectable market share, detailed complex injectable market segments, market trends, and opportunities, and any further data you may need to thrive in the complex injectable industry. This complex injectable market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The complex injectable market size has grown rapidly in recent years. It will grow from $17.70 billion in 2024 to $19.77 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historic period is linked to increasing prevalence of chronic diseases, rising demand for targeted biologic therapies, growing adoption of self-administration devices, expanding applications in oncology, and higher regulatory approvals for biosimilars.
The complex injectable market size is expected to see rapid growth in the next few years. It will grow to $30.38 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth projected for the forecast period is driven by growing focus on personalized medicine, increasing healthcare expenditure, expanding applications in autoimmune disorders, rising patient preference for minimally invasive treatments, and higher demand for self-administration devices. Primary trends during the forecast period include advancements in biologic therapies, technological innovations in drug delivery systems, developments in nanotechnology for targeted delivery, improvements in cold chain logistics, and progress in injectable peptide and protein therapeutics.
The rising prevalence of chronic diseases is expected to drive growth in the complex injectable market in the coming years. Chronic diseases are long-term medical conditions that generally progress slowly and require continuous management. Factors such as aging populations contribute to this increase, as older adults are more prone to conditions such as diabetes, heart disease, and arthritis. Complex injectables aid in managing these chronic illnesses by delivering targeted medications that help control symptoms and slow disease progression. For example, the Office for Health Improvement & Disparities (OHID), a UK-based public health agency, projects that the global number of adults living with diabetes will increase from 537 million in 2021 to 643 million by 2030. Thus, the growing burden of chronic diseases is driving demand in the complex injectable market.
Leading companies in drug delivery systems are focusing on innovations such as autoinjector dosage forms to improve patient convenience, enhance treatment adherence, ensure precise and safe drug administration, and facilitate effective delivery of complex biologic therapies. Autoinjectors are pre-filled, self-administered injection devices designed to safely and accurately deliver a specific medication dose, often used for biologics and other complex drugs. For instance, in January 2024, Taisho Pharmaceutical Co. Ltd., a Japan-based generic drug manufacturer, launched Nanozora 30 mg for subcutaneous injection. This patient-friendly device allows for easy self-administration and includes a needle-covering feature to prevent accidental needle sticks. It enables patients with rheumatoid arthritis to conveniently receive treatment once every four weeks, broadening Taisho's treatment options beyond its existing syringe formulations.
In April 2024, Eli Lilly and Company, a US-based pharmaceutical giant, acquired Nexus Pharmaceuticals Inc. for an undisclosed sum. This acquisition expands Lilly's parenteral (injectable) manufacturing capabilities by incorporating Nexus's advanced sterile manufacturing facility. The move strengthens Lilly's ability to meet increasing demand for complex injectable drugs and supports its robust pipeline targeting conditions such as diabetes, obesity, and migraine. Nexus Pharmaceuticals Inc. is a US-based firm specializing in the development and production of generic and specialty injectable medications.
Major players in the complex injectable market are Johnson & Johnson Pharmaceutical, Merck & Co. Inc., Pfizer Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Novo Nordisk, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim GmbH, Baxter Healthcare Corporation, Fresenius Kabi, Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Indivior PLC, Amphastar Pharmaceuticals Inc., Braun Melsungen AG, Ferring Pharmaceuticals, Oakwood Labs, ForDoz Pharma.
North America was the largest region in the complex injectable market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in complex injectable report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the complex injectable market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The complex injectable market consists of sales of liposomal injections, depot injections, nanoparticle-based injectables, emulsions, and suspensions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Complex Injectable Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on complex injectable market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for complex injectable ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The complex injectable market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Monoclonal Antibodies; Gene Therapies; Vaccines Proteins and Peptides; Antibody-Drug Conjugates (ADCs)
3) By Route of Administration: Intravenous (IV); Subcutaneous (SC); Intramuscular (IM); Epidural; Intradermal
4) By Distribution Channel: Direct Sale; Pharmacies; eCommerce; Distributors; Wholesalers
5) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Home Healthcare; Research Institutions
Subsegments:
1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies; Humanized Monoclonal Antibodies; Fully Human Monoclonal Antibodies; Bispecific Monoclonal Antibodies
2) By Gene Therapies: Somatic Gene Therapy; Germline Gene Therapy; Ex Vivo Gene Therapy; In Vivo Gene Therapy
3) By Vaccines, Proteins And Peptides: Recombinant Proteins; Synthetic Peptides; mRNA Vaccines; Viral Vector Vaccines
4) By Antibody Drug Conjugates: Cleavable Linker Antibody Drug Conjugates; Non-cleavable Linker Antibody Drug Conjugates; Cytotoxic Payload Antibody Drug Conjugates; Target-specific Antibody Drug Conjugates
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Complex Injectable Market Characteristics
3. Complex Injectable Market Trends And Strategies
4. Complex Injectable Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Complex Injectable Growth Analysis And Strategic Analysis Framework
5.1. Global Complex Injectable PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Complex Injectable Market Growth Rate Analysis
5.4. Global Complex Injectable Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Complex Injectable Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Complex Injectable Total Addressable Market (TAM)
6. Complex Injectable Market Segmentation
6.1. Global Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Gene Therapies
Vaccines Proteins and Peptides
Antibody-Drug Conjugates (ADCs)
6.2. Global Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Diabetes
Autoimmune Disorders
Neurological Disorders
Cardiovascular Diseases
Infectious Diseases
6.3. Global Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous (IV)
Subcutaneous (SC)
Intramuscular (IM)
Epidural
Intradermal
6.4. Global Complex Injectable Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Direct Sale
Pharmacies
eCommerce
Distributors
Wholesalers
6.5. Global Complex Injectable Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Home Healthcare
Research Institutions
6.6. Global Complex Injectable Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chimeric Monoclonal Antibodies
Humanized Monoclonal Antibodies
Fully Human Monoclonal Antibodies
Bispecific Monoclonal Antibodies
6.7. Global Complex Injectable Market, Sub-Segmentation Of Gene Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Somatic Gene Therapy
Germline Gene Therapy
Ex Vivo Gene Therapy
In Vivo Gene Therapy
6.8. Global Complex Injectable Market, Sub-Segmentation Of Vaccines, Proteins & Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Proteins
Synthetic Peptides
mRNA Vaccines
Viral Vector Vaccines
Protein Subunit Vaccines
6.9. Global Complex Injectable Market, Sub-Segmentation Of Antibody Drug Conjugates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cleavable Linker Antibody Drug Conjugates
Non Cleavable Linker Antibody Drug Conjugates
Cytotoxic Payload Antibody Drug Conjugates
Target Specific Antibody Drug Conjugates
7. Complex Injectable Market Regional And Country Analysis
7.1. Global Complex Injectable Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Complex Injectable Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Complex Injectable Market
9.1. China Complex Injectable Market Overview
9.2. China Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Complex Injectable Market
10.1. India Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Complex Injectable Market
11.1. Japan Complex Injectable Market Overview
11.2. Japan Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Complex Injectable Market
12.1. Australia Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Complex Injectable Market
13.1. Indonesia Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Complex Injectable Market
14.1. South Korea Complex Injectable Market Overview
14.2. South Korea Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Complex Injectable Market
15.1. Western Europe Complex Injectable Market Overview
15.2. Western Europe Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Complex Injectable Market
16.1. UK Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Complex Injectable Market
17.1. Germany Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Complex Injectable Market
18.1. France Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Complex Injectable Market
19.1. Italy Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Complex Injectable Market
20.1. Spain Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Complex Injectable Market
21.1. Eastern Europe Complex Injectable Market Overview
21.2. Eastern Europe Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Complex Injectable Market
22.1. Russia Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Complex Injectable Market
23.1. North America Complex Injectable Market Overview
23.2. North America Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Complex Injectable Market
24.1. USA Complex Injectable Market Overview
24.2. USA Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Complex Injectable Market
25.1. Canada Complex Injectable Market Overview
25.2. Canada Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Complex Injectable Market
26.1. South America Complex Injectable Market Overview
26.2. South America Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Complex Injectable Market
27.1. Brazil Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Complex Injectable Market
28.1. Middle East Complex Injectable Market Overview
28.2. Middle East Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Complex Injectable Market
29.1. Africa Complex Injectable Market Overview
29.2. Africa Complex Injectable Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Complex Injectable Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Complex Injectable Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Complex Injectable Market Competitive Landscape And Company Profiles
